Follicular lymphoma - rituximab (review): consultee and commentator comments on the ACD
Follicular lymphoma - rituximab (review): comments from School of Health and Related Research
Follicular lymphoma - rituximab (review): comments from Roche Pharmaceuticals
Follicular lymphoma - rituximab (review): comments from Lymphoma association and Leukaemia Care
Follicular lymphoma - rituximab (review): comments from Royal College of Physicians
Follicular lymphoma - rituximab (review): comments from Healthcare Improvement Scotland
Follicular lymphoma - rituximab (review): comments from Commissioning Support Appraisals Service
This page was last updated: 28 November 2011